TP73 and cholangiocarcinoma: Studies have shown that TP73-AS1 is upregulated in the majority of solid tumors, including gastric cancer (GC) [10,11], lung cancer [12,13], colorectal cancer (CRC) [14], cervical cancer (CC) [15], and hepatocellular carcinoma (HCC) [16].